Megpro 160 Tablet contains Megestrol acetate 160 mg, a synthetic derivative of the naturally occurring hormone progesterone. It is primarily indicated for the management of anorexia, cachexia, or significant unexplained weight loss in patients with chronic illnesses such as cancer and acquired immunodeficiency syndrome (AIDS). Megestrol acts as an appetite stimulant and promotes weight gain by modulating the hypothalamic appetite control center and exerting antineoplastic effects in hormone-responsive tumors. The tablet is administered orally and should be used under medical supervision, with dosage tailored according to the patient's clinical condition and response. Common adverse effects may include nausea, vomiting, edema, thromboembolic events, and changes in blood glucose levels, necessitating regular monitoring during therapy. Megpro 160 is contraindicated in patients with known hypersensitivity to megestrol or any component of the formulation, and caution is advised in individuals with a history of thromboembolic disorders or uncontrolled diabetes mellitus. It is not recommended for use during pregnancy due to potential teratogenic effects. Clinicians should evaluate the risk-benefit profile before initiating treatment and counsel patients regarding potential side effects and the importance of adherence to prescribed regimens.